Bind at the Research Ventures Catalyst Investor Event
July 11, 2024
admin
Bind is pitching at the Investor Event for the Research Ventures Catalyst programme. Find us at the Francis Crick Institute on July 23rd (more information here).
July 11, 2024
admin
Bind is pitching at the Investor Event for the Research Ventures Catalyst programme. Find us at the Francis Crick Institute on July 23rd (more information here).
Got an IDP target? We’d love to hear from you. Intrinsically disordered proteins are implicated in some of the most important and least-treated diseases in human health, but for a long time the tools to drug them simply didn’t exist. At Bind, we’re building those tools, and we want to put them to work on […]
19 Mar 2026
On 19 March 2026, Bind Research officially launched to an audience of more than 300 scientists, investors, policymakers, clinicians and technologists at One Triton Square, London. The event was hosted by VentureCafé London, sponsored by ARIA. The evening featured two keynote speakers. Professor Sheena Radford OBE FRS FMedSci spoke about why intrinsically disordered proteins remain […]
19 Mar 2026
30% of the human proteome is intrinsically disordered. Almost none of it is considered druggable. That is one of the largest unmet opportunities in medicine. Bind has recently published two papers setting out exactly why disordered proteins have resisted drug discovery for so long. The barriers are real: no stable binding pockets, no scalable measurement […]
18 Mar 2026